Evidence map›Paper›PMID 37382792›Full record

ArticleApplied biochemistry and biotechnology2024

Hepatic Sinusoid Capillarizate via IGTAV/FAK Pathway Under High Glucose.

Jia Liu, Hengjiang Gong, Jinxing Quan, Limin Tian, Qi Zhang, Juxiang Liu, Dongquan Zhang, Jing Liu

Erratum issuedAbstract read
PubMed Publisher
In one paragraph

Article in Applied biochemistry and biotechnology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.7field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Jia LiuThe First Clinical College of Lanzhou University, Lanzhou, 730000, Gansu province, China.
Hengjiang GongDepartment of General Practice, The First Hospital of Lanzhou University, Lanzhou city, 730000, Gansu province, China.
Jinxing QuanDepartment of Endocrinology, Gansu Provincial Hospital, Donggang west Road 160, Lanzhou city, 730000, Gansu province, China.
Limin TianDepartment of Endocrinology, Gansu Provincial Hospital, Donggang west Road 160, Lanzhou city, 730000, Gansu province, China.
Qi ZhangDepartment of Endocrinology, Gansu Provincial Hospital, Donggang west Road 160, Lanzhou city, 730000, Gansu province, China.
Juxiang LiuDepartment of Endocrinology, Gansu Provincial Hospital, Donggang west Road 160, Lanzhou city, 730000, Gansu province, China.
Dongquan ZhangDepartment of Intensive Care, Gansu Provincial Hospital, Lanzhou city, 730000, Gansu province, China.
Jing LiuThe First Clinical College of Lanzhou University, Lanzhou, 730000, Gansu province, China. yongshen986@163.com.
Gansu Provincial Hospital · CNLanzhou University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The incidence of diabetic patients with non-alcoholic fatty liver disease (NAFLD) is continuously increasing worldwide. However, the specific mechanisms of NAFLD patients with diabetes are still not clear. Recent studies have indicated that integrins play an important role in NAFLD. In this study, we considered the relationship between integrin αv (IGTAV)/FAK pathway and sinusoidal capillarization. We investigated the difference between the expression of IGTAV, laminin (LN), focal adhesion kinase (FAK), and phosphor-FAK protein in human liver sinusoidal endothelial cells (HLSECs) to explore the specific mechanisms of the diseases of NAFLD with diabetes under high glucose. We cultured and identified the HLSECs and constructed the recombinant lentivirus vector with IGTAV shRNA by quantitative real-time PCR (qRT-PCR) to silence the IGTAV gene. Cells were divided into groups of 25 mmol/L glucose and 25 mmol/L mannitol. We measured the protein levels of IGTAV, LN, FAK, and phosphor-FAK by western blot at 2 h, 6 h, and 12 h before and after IGTAV gene silencing. The lentivirus vector was successfully constructed with IGTAV shRNA. The HLSECs under high glucose were observed by scanning electron microscope. SPSS19.0 was used for statistical analysis. High glucose significantly increased the expression of IGTAV, LN, and phosphor-FAK protein in HLSECs; the shRNA IGTAV could effectively inhibit the expression of phosphor-FAK and LN at 2 h and 6 h. Inhibition of the phosphor-FAK could effectively decrease the expression of LN in HLSECs at 2 h and 6 h under high glucose. Inhibition of IGTAV gene of HLSECs under high glucose could improve hepatic sinus capillarization. Inhibition of IGTAV and phosphor-FAK decreased the expression of LN. High glucose led to hepatic sinus capillarization via IGTAV/ FAK pathway.

Indexed as

Diabetes MellitusNon-alcoholic Fatty Liver DiseaseCapillariesEndothelial CellsFocal Adhesion Protein-Tyrosine KinasesGlucoseHumansIntegrin alphaVRNA, Small InterferingFocal Adhesion Protein-Tyrosine KinasesGlucoseIntegrin alphaVRNA, Small InterferingFocal adhesion kinaseHigh glucoseIntegrin αvLamininNAFLDSinusoid capillarization

Identifiers

PMID37382792
OpenAlexW4382501462

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.